September 19, 2016

DrugDev Drives Adoption of Disruptive Technology to Advance Clinical Trials at Pharma Industry Events in Q3 and Q4

DrugDev executives will be speaking and participating in conferences and competitions around the globe this fall as they continue to spread the message about the benefits sponsors, sites and patients can achieve together by using technology and new processes to optimize clinical operations. The fall event schedule includes participation in the following conferences and meetings and competitions:

“Inspiring Hope” Ideathon, September 27-28 in Boston MA
DrugDev is the sole Platinum Sponsor for this event organized by strategic partner INC Research and CISCRP (The Center for Information & Study on Clinical Research Participation) to raise awareness of clinical research among patients, healthcare professionals, and the public. DrugDev Executive Chairman Hugo Stephenson MD will join industry colleagues to judge finalists. Hugo, who is a Principal Investigator, Head of the DrugDev Innovation Lab, and Executive Chairman at DrugDev commented, “Clinical trials give patients and their doctors a vital opportunity to test new treatments that can greatly improve quality of life, but 95% of the public doesn’t participate in trials because of a lack of awareness and misconceptions. DrugDev’s mission is to help researchers and patients do more clinical trials, so we’re thrilled to support CISCRP and INC Research in the ‘Inspiring Hope’ Ideathon and to be involved with the creation of new ideas to advance the clinical trial process.” DrugDev has a long history of supporting CISCRP, most recently sponsoring 100 runners for the Medical Heroes Appreciation 5K at the DIA 52nd Annual Meeting. Learn more about CISCRP and the “Inspiring Hope” Ideathon:

Site Solutions Summit – US, October 13-16 in Boca Raton, FL
DrugDev is a sponsor and exhibitor at this conference where sites, sponsors, CRO executives, and regulators come together. Hugo Stephenson will judge Site Tank™, a competition for sites where they share technology ideas that enhance, empower and improve site operations and transform their business model. DrugDev Founder and President of Site Startup Melissa “Liss” Easy – whose vision led DrugDev to amass an unequaled network of 80,000+ active investigators in 120 countries and to create site activation technology that decreases site startup time from 20-40% – also will participate in the conference.

The Conference Forum’s Disruptive Innovations US (DPharm), September 20-21 in Boston MA
DrugDev is a sponsor, and attendees will include CEO Ibraheem “Ibs” Mahmood and President of the DrugDev Platform Eric Silberstein.

MAGI West, October 23-26 in Las Vegas NV
DrugDev Contract Manager for Site Startup Nicole Wrenn will present “Efficient Contract & Budget Negotiation; Saving Time and Energy at the Front End,” in session A478.

Additionally, DrugDev executives will participate in Outsourcing Clinical Trials Southern California, October 26-27 in La Jolla CA, and Partnerships in Clinical Trials Europe, November 16-17 in Vienna, Austria, and will sponsor and present at the CBI/SCRS CTA, Investigator Payments and FMV Conference, December 6-7 in Philadelphia PA.

To arrange a meeting or demonstration with DrugDev at these events email solutions(at)drugdev(dot)com

About DrugDev
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn more at